BP Capital Markets PLC Publication of Suppl.Prospcts (6150F)
22 Março 2022 - 8:52AM
UK Regulatory
TIDM74WM
RNS Number : 6150F
BP Capital Markets PLC
22 March 2022
Publication of Supplementary Prospectus
The following supplementary prospectus has been approved by the
Financial Conduct Authority and is available for viewing:
Supplementary prospectus dated 22 March 2022 (the "Supplementary
Prospectus") relating to the prospectus dated 6 August 2021 (the
"Prospectus") relating to the U.S.$40,000,000,000 Debt Issuance
Programme issued by BP Capital Markets p.l.c. and BP Capital
Markets B.V. unconditionally and irrevocably guaranteed by BP
p.l.c.
To view the Supplementary Prospectus, please paste the following
URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/6150F_1-2022-3-22.pdf
A copy of the Supplementary Prospectus and the documents
incorporated by reference therein will be submitted to the National
Storage Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
For further information, please contact:
BP Capital Markets p.l.c.
20 Canada Square
Canary Wharf
London E14 5NJ
United Kingdom
Tel: +44 (0) 20 3683 0901
Fax: +44 (0) 20 7948 7783
Attention: Gary Admans
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus may
be addressed to and/or targeted at persons who are residents of
particular countries (specified in the Prospectus) only and is not
intended for use and should not be relied upon by any person
outside these countries and/or to whom the Prospectus is not
addressed. Prior to relying on the information contained in the
Prospectus you must ascertain from the Prospectus whether or not
you are part of the intended addressees of the information
contained therein.
Your right to access this service is conditional upon complying
with the above requirement.
The Prospectus does not constitute an offer of securities for
sale in the United States. The securities described in the
Prospectus have not been, and will not be, registered under the
U.S. Securities Act of 1933, as amended, or under any relevant
securities laws of any state of the United States of America and
may not be offered, sold or delivered in the United States of
America or to, or for the account of or benefit of, U.S. Persons,
subject to certain limited exemptions.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PSPDZGZFMZRGZZM
(END) Dow Jones Newswires
March 22, 2022 07:52 ET (11:52 GMT)
Bp Cap 29 (LSE:74WM)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Bp Cap 29 (LSE:74WM)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024